NRX Pharmaceuticals, Inc. Common Stock (NRXP)
NRX Pharmaceuticals, Inc. Common Stock (NRXP) has reported earnings 9 times since Nov 14, 2022. The stock moves an average of ±5.50% the day after reporting, closing higher 44.4% of the time. Its largest post-earnings gain was +9.21% (Nov 15, 2024) and its largest decline was -12.87% (Nov 14, 2022). The next earnings report is predicted for 2026-08-14 (approximate).
Earnings reactions
How NRXP moved on each past earnings report.
Earnings Impact
Total Earnings
9
Avg Abs. Movement
±5.50%
Positive %
44.4%
Negative %
55.6%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 18, 2025 | ☽ POST | -8.5% | open_in_new |
| May 21, 2025 | ☽ POST | +7.2% | open_in_new |
| Mar 21, 2025 | ☽ POST | -2.15% | open_in_new |
| Nov 15, 2024 | ☽ POST | +9.21% | open_in_new |
Earnings Count
9
Total earnings in dataset
Avg Abs. Movement
±5.50%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260722 | open_in_new SEC.gov |
| 8-K | 20260604 | open_in_new SEC.gov |
| 424B5 | 20260603 | open_in_new SEC.gov |
| 424B5 | 20260602 | open_in_new SEC.gov |
| 8-K | 20260602 | open_in_new SEC.gov |
| 25-NSE | 20260522 | open_in_new SEC.gov |
| 10-Q | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| CORRESP | 20251218 | open_in_new SEC.gov |
| UPLOAD | 20250624 | open_in_new SEC.gov |
Frequently asked about NRXP earnings
When does NRX Pharmaceuticals, Inc. Common Stock report earnings next? expand_more
NRX Pharmaceuticals, Inc. Common Stock (NRXP)'s next earnings date is approximate for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does NRXP stock move after earnings? expand_more
Over 9 reports, NRXP has moved an average of ±5.50% the session after earnings, closing higher 44.4% of the time.
What was NRXP's biggest post-earnings move? expand_more
NRXP's largest post-earnings gain on record was +9.21% on Nov 15, 2024, and its largest decline was -12.87% on Nov 14, 2022.
Where can I find NRX Pharmaceuticals, Inc. Common Stock's SEC filings? expand_more
All of NRX Pharmaceuticals, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right